multiparametric MRI Archives - Page 19 of 20

A Critique of Transperineal Biopsy Study On MRI/Ultrasound Fusion Guidance

I read a study on the accuracy of prostate MRI for predicting that no prostate cancer (PCa) is present. This is called the negative predictive value (NPV), and the authors make a great point in their introduction: The reliability of a negative MRI is a key clinical metric – if the MRI is reported as keep reading

Does Money Buy Life?

Everyone knows that money doesn’t buy happiness. But can it buy life? A new study out of the University of Washington Medical Center suggests that prostate cancer patients in extreme financial distress are more likely to die than those who are not. This doesn’t mean that having money can buy life, but hardship is a keep reading

Great News About Multiparametric MRI

It is always gratifying for a doctor when something he or she wholeheartedly believes in gets affirmed by published research. For me, this is the case with a new Italian study, “The Roles of Multiparametric MRI, PCA3, and PHI: Which Is The Best Predictor of Prostate Cancer After a Negative Biopsy?”[i] The authors recognize the keep reading

Don’t Be the Victim of Prostate Cops

When you’re cruising along in good health, it’s easy to take that smooth road for granted. An annual physical with a PSA is a little like stopping at a red light and waiting till the light changes. When the physical ends, you figure it’s a green light and leave the office, expecting to go on keep reading

An Update on the Current Role for Prostate Multiparametric MRI

A prominent urologist wrote an articulate article on how the U.S. Preventive Services Task Force made a recommendation against broad PSA screening based on an oversimplification of a complex issue. He made an eloquent declaration on several ways in which urologists are “embracing strategies to preserve, or even further decrease, prostate cancer mortality while minimizing keep reading

Multiparametric MRI Adds Value to Surveillance Monitoring

It’s always reassuring to receive affirmation, especially when offering a leading edge medical program to prostate cancer patients. Such was the case for us at the Sperling Prostate Center with the December, 2015 publication of a UCLA Medical Center study on the value-added of multiparametric MRI during Active Surveillance (AS). The authoritative Journal of Urology keep reading

The Right Way to do Active Surveillance

We know that the use of Active Surveillance (AS) as a way to hold off on prostate cancer (PCa) treatment is on the rise. Concerns about overtreatment, such as doing a prostatectomy on a patient who only has a small Gleason 3+3 tumor, stem from two recognized realities: Insignificant PCa may be slow-growing (indolent) and keep reading

The PSA Screening Debate

On November 18, 2015 the New York Times carried an article titled “Early Prostate Cancer Cases Fall Along With Screening.” Ever since the U.S. Preventive Services Task Force recommended against broad PSA screening on the grounds that it leads to overdetection and overtreatment, two opposing positions have been created. One position favors the recommendation on keep reading

A Brief Imaging Update

Roughly 14% of American men will be diagnosed with prostate cancer (PCa) in their lifetime. It is the second leading cause of death in men, after lung cancer—yet it is a highly curable disease if caught early, and if choice of treatment matches the disease. This year, over 220,000 new cases will be diagnosed. Today, keep reading

Poverty and Prostate Cancer Risk

I have written past blogs about physical factors that increase the risk of dying from prostate cancer: genetic history, exposure to toxic agents, alcohol abuse, smoking, too much red meat, precursor conditions such as high grade PIN and ASAP, etc. However, there’s another risk factor that does not occur within the body, but certainly affects keep reading

Tag: multiparametric MRI